Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 + 1457 word(s) 1457 2021-05-10 11:17:06 |
2 Format correct Meta information modification 1457 2021-05-31 06:25:52 |

Video Upload Options

Do you have a full video?


Are you sure to Delete?
If you have any further questions, please contact Encyclopedia Editorial Office.
Nombela Diaz, I. Transportin-SR2 in HIV nuclear import. Encyclopedia. Available online: (accessed on 15 April 2024).
Nombela Diaz I. Transportin-SR2 in HIV nuclear import. Encyclopedia. Available at: Accessed April 15, 2024.
Nombela Diaz, Ivan. "Transportin-SR2 in HIV nuclear import" Encyclopedia, (accessed April 15, 2024).
Nombela Diaz, I. (2021, May 28). Transportin-SR2 in HIV nuclear import. In Encyclopedia.
Nombela Diaz, Ivan. "Transportin-SR2 in HIV nuclear import." Encyclopedia. Web. 28 May, 2021.
Transportin-SR2 in HIV nuclear import

Transportin-SR2 (TRN-SR2), also known as transportin-3 or TNPO3, is a karyopherin involved in the nuclear import of specific cargoes, such as serine/arginine-rich molecules. This molecule has been implicated in human diseases such as primary biliary cirrhosis and limb-girdle muscular dystrophy. TRN-SR2 is also known to play a role in HIV-1 nuclear import.

HIV-1 nuclear import integrase capsid transportin-SR2 TRN-SR2 TNPO3 transportin-3 CPSF6 nuclear pore

1. Introduction

For productive infection, most DNA viruses and a few RNA viruses including Orthomyxoviridae and Retroviridae have to pass the barrier of the nuclear membrane to deliver their genome into the nucleus. Therefore, these viruses have evolved to exploit the complex machinery of nuclear trafficking [1][2]. Lentiviridae such as the human immunodeficiency virus type 1 (HIV-1) are able to infect non-dividing cells like resting lymphocytes, macrophages and dendritic cells [1][3]. Classical studies showed that the nuclear envelope (NE) restricts access to the nucleus as only molecules smaller than 40 kDa or a diameter up to 5 nm can passively diffuse through the NPC [4][5]. Interestingly a recent study showed that the nuclear pore complex (NPC) represents a soft barrier to passive diffusion rather than a rigid barrier. However, the NPC contains FG domains with high net charge and low hydropathy near the cytoplasmic end of the central channel that limit the passive diffusion of macromolecules [6]. HIV-1 and other lentiviruses interact with the nuclear pores and its associated receptors and proteins through an active nuclear import mechanism that remains poorly understood. Among all HIV-1 preintegration complex (PIC) components, the viral cDNA, integrase (IN), reverse transcriptase (RT), capsid (CA), matrix antigen (MA) and viral protein R (Vpr) have all been proposed as the most important factor for HIV nuclear import [7][8][9][10][11][12]. Yet, the exact role of the viral determinants and host factors remains a subject of debate. 

2. Implications of TRN-SR2 in nuclear import

TRN-SR2 was discovered as one the major HIV nuclear import determinants by Christ et al. [13]. Later, its ability to interact with HIV integrase was confirmed [14]. Depletion of TRN-SR2 resulted in a decrease of HIV infectivity and a reduced number of nuclear HIV PICs [13]. Another host factor, known as cleavage and polyadenylation specificity factor subunit 6, is imported by TRN-SR2 in the nucleus [15]. CPSF6 has been implicated in several steps in the replication cycle of HIV-1: it has been proposed as a trafficking factor in the cytoplasm [16], as a mediator of nuclear import [17] and as a major determinant of the integration site selection [18]. Its role in HIV replication was first identified in a cDNA expression screen that yielded a truncated version (CPSF6-358) that acts as a transdominant inhibitor of HIV nuclear import [19] and a restriction factor [20]. Later, the ability of CPSF6 to interact with HIV CA was discovered [15]. This interaction is mediated by a pocket formed between the N-terminal domain and the C-terminal domain of adjacent CA subunits [21]

Nevertheless, the role of TRN-SR2 and CPSF6 have been linked because TRN-SR2 is the karyopherin importing CPSF6 to the nucleus [22]. Several structural models explaining the interactions between TRN-SR2, CPSF6 and HIV IN have been proposed. A first model proposed that HIV PIC is translocated to the nucleus by a direct interaction between TRN-SR2 and HIV IN [23] (Figure 1A). This study used a HIV IN mutant R263A/K264A that showed less infectivity and interaction with TRN-SR2. Later, another model proposed that one molecule of TRN-SR2 interacts with the catalytic and C-terminal domains of HIV IN without involvement of the SR binding region [24] (Figure 1B). This implies that TRN-SR2 could bind splicing factors (such as CPSF6) or other natural cargoes avoiding interference of HIV with nuclear import. In the last model, TRN-SR2 would act as a mere mediator of the nuclear import of CPSF6, which would be mediating the interaction with the HIV PIC (Figure 1C) To date, studies produced conflicting results with respect to the importance of CPSF6 and TRN-SR2 for HIV replication.

Figure 1. Nuclear import models for TRN-SR2: (A) TRN-SR2 can interact directly with HIV integrase, (B) Tsirkone et al. proposed a model where TRN-SR2 could accommodate both HIV IN and CPSF6 in a noncompetitive manner, (C) according to the third model, CPSF6 plays the key role in the interaction with the HIV PIC. 

3. Implications of TRN-SR2 in uncoating

It is difficult to ignore the process of HIV-1 uncoating when talking about HIV-1 nuclear import. Since, HIV-1 uncoating is key in understanding nuclear import, any nuclear import model will depend on the model of uncoating chosen. To date three different models of HIV-1 uncoating are put forward with data in favor or against (Figure 2). The first model proposes early uncoating shortly after HIV-1 fusion with the cell membrane and the release of the viral core into the cytoplasm (Figure 2A) [25][26][27][28]. However, based on live cell imaging and single particle tracking, the early uncoating hypothesis is not any longer accepted as the prevailing model. The second HIV-1 uncoating mechanism is based on studies from Francis et al., Borrenberghs et al. and Zurnic et al[29][30][31]. This uncoating model proposes uncoating to take place at the NE while the viral core is docked to the NPC (Figure 2B). The mechanism of action of PF74 that induces premature uncoating and inhibits the RT step was consistent with this model. Alternatively, PF74 may block the interaction of N74D in CA with Nup153 and/or CPSF6 blocking nuclear import. That mechanism would be consistent with the second or third uncoating models. This model is consistent with the reduction of IN content detected in nuclear versus cytoplasmic PICs [29][32] and the LEDGF/p75-mediated increase in FRET ratio of IN upon nuclear entry [29]. The model is also consistent with a reduction in the amount of CA associated with nuclear PICs, although staining may be confounded by interaction partners such as CPSF6. Of note capsid proteins may reassemble inside the nucleus, as is the case with the hepatitis B virus [2]. In 2020 Burdick et al. presented a third model of uncoating whereby intact cones enter the nucleus, complete reverse transcription and integration takes place 1–2 h after uncoating (Figure 2C) [33][34]. The mechanism of action of PF74 that induces premature uncoating at higher concentrations and inhibits the RT step was consistent with the second model.

A favorite scenario for HIV-1 nuclear import according to findings of several research groups is shown in Figure 3, although the exact details still need to be clarified. Cytoplasmic filaments of NUPs mainly consisting of the NUP358 interacting with the CypA binding motif in HIV-1 CA and facilitating docking to the NE. During their residency at the NPC CA interacted with NUP153 in the nuclear basket. Physical stress following completion of reverse transcription shears the narrow end of the cone residing in the nuclear basket. CPSF6 may be recruited to the NPC by its physical interaction with CA. The HIV-1 IN complex interacted with the HEAT repeats in the N-terminal half of TRN-SR2 and since this interaction did not involve the SR-binding region, PICs can be smuggled during TRN-SR2-mediated nuclear import of CPSF6. Nuclear CPSF6 competed with the interaction of Nup153 with the CA residues in the cone stuck in the NPC. Competition between nuclear CPSF6 released the capsid remnants from the nuclear basket (Figure 3). Ran-GTP dissociates IN from TRN-SR2. LEDGF/p75 altered the IN conformation prior to integration. In the absence of CPSF6 (by depletion of for the N74D mutant) this nuclear import pathway was aborted; instead, PICs integrated while still associated with the basket of the NPC.

Figure 2. Models of HIV-1 uncoating. To date three potential models for HIV-1 uncoating are proposed. “Immediate uncoating” points to the early disassembly of the HIV-1 core inside the cytoplasm during the first hour of infection and prior to NPC docking (A). Uncoating at the NE is supported by imaging experiments showing that uncoating occurs when the core is stalled at the NPC. (B). Recent studies are claiming a “nuclear uncoating” mechanism and represent the third model of HIV-1 uncoating (C). In the third model, intact HIV-1 cones enter into the cell nucleus, reverse transcription is completed, and uncoating and integration are all completed inside the nucleus and close to the integration site.

Figure 3. HIV-1 nuclear import. Interaction between Nup358 and viral CA results in docking of HIV-1 cones to the NE. Depending on the model chosen (see Figure 2) capsid uncoating occurs in the cytoplasm, at the NE, or in the nucleus. Interaction between Nup153 and CA results in docking to the nuclear basket of the NPC. CPSF6 bound to CA proteins may recruit TRN-SR2 to the PICs. After capsid uncoating the triple complex of transportin-SR2/HIV-1 IN/CPSF6 may subsequently translocate the viral integration complex into the nucleus. Binding of nuclear CPSF6 molecules to CA remnants may release these remnants into the nucleoplasm.

Cover picture: TRN-SR2 - Ran complex. Source:


  1. Mettenleiter, T.C. Breaching the barrier—The nuclear envelope in virus infection. J. Mol. Biol. 2016, 428, 1949–1961.
  2. Gallucci, L.; Kann, M. Nuclear import of hepatitis B virus capsids and genome. Viruses 2017, 9, 21.
  3. Katz, R.A.; Greger, J.G.; Boimel, P.; Skalka, A.M. Human immunodeficiency virus type 1 DNA nuclear import and integration are mitosis independent in cycling cells. J. Virol. 2003, 77, 13412–13417.
  4. Wente, S.R.; Rout, M.P. The nuclear pore complex and nuclear transport. Cold Spring Harbor Perspect. Biol. 2010, 2, a000562.
  5. Keminer, O.; Peters, R. Permeability of single nuclear pores. Biophys. J. 1999, 77, 217–228.
  6. Timney, B.L.; Raveh, B.; Mironska, R.; Trivedi, J.M.; Kim, S.J.; Russel, D.; Wente, S.R.; Sali, A.; Rout, M.P. Simple rules for passive diffusion through the nuclear pore complex. J. Cell Biol. 2016, 215, 57–76.
  7. Christ, F.; Thys, W.; De Rijck, J.; Gijsbers, R.; Albanese, A.; Arosio, D.; Emiliani, S.; Rain, J.-C.; Benarous, R.; Cereseto, A. Transportin-SR2 imports HIV into the nucleus. Curr. Biol. 2008, 18, 1192–1202.
  8. Krishnan, L.; Matreyek, K.A.; Oztop, I.; Lee, K.; Tipper, C.H.; Li, X.; Dar, M.J.; KewalRamani, V.N.; Engelman, A. The requirement for cellular transportin 3 (TNPO3 or TRN-SR2) during infection maps to human immunodeficiency virus type 1 capsid and not integrase. J. Virol. 2010, 84, 397–406.
  9. Arnold, M.; Nath, A.; Hauber, J.; Kehlenbach, R.H. Multiple importins function as nuclear transport receptors for the Rev protein of human immunodeficiency virus type 1. J. Biol. Chem. 2006, 281, 20883–20890.
  10. Gallay, P.; Swingler, S.; Aiken, C.; Trono, D. HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell 1995, 80, 379–388.
  11. Heinzinger, N.K.; Bukinsky, M.; Haggerty, S.A.; Ragland, A.M.; Kewalramani, V.; Lee, M.-A.; Gendelman, H.E.; Ratner, L.; Stevenson, M.; Emerman, M. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA 1994, 91, 7311–7315.
  12. Zennou, V.; Petit, C.; Guetard, D.; Nerhbass, U.; Montagnier, L.; Charneau, P. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 2000, 101, 173–185.
  13. Frauke Christ; Wannes Thys; Jan De Rijck; Rik Gijsbers; Alberto Albanese; Daniele Arosio; Stephane Emiliani; Jean-Christophe Rain; Richard Benarous; Anna Cereseto; et al.Zeger Debyser Transportin-SR2 Imports HIV into the Nucleus. Current Biology 2008, 18, 1192-1202, 10.1016/j.cub.2008.07.079.
  14. Ross Larue; Kushol Gupta; Christiane Wuensch; Nikolozi Shkriabai; Jacques J. Kessl; Eric Danhart; Lei Feng; Oliver Taltynov; Frauke Christ; Gregory D. Van Duyne; et al.Zeger DebyserMark P. FosterMamuka Kvaratskhelia Interaction of the HIV-1 Intasome with Transportin 3 Protein (TNPO3 or TRN-SR2)*. Journal of Biological Chemistry 2012, 287, 34044-34058, 10.1074/jbc.m112.384669.
  15. Amanda J. Price; Adam J. Fletcher; Torsten Schaller; Tom Elliott; KyeongEun Lee; Vineet N. KewalRamani; Jason W. Chin; Gregory Towers; Leo C. James; CPSF6 Defines a Conserved Capsid Interface that Modulates HIV-1 Replication. PLOS Pathogens 2012, 8, e1002896, 10.1371/journal.ppat.1002896.
  16. Zhou Zhong; Jiying Ning; Emerson A. Boggs; Sooin Jang; Callen Wallace; Cheryl Telmer; Marcel P. Bruchez; Jinwoo Ahn; Alan N. Engelman; Peijun Zhang; et al.Simon C. WatkinsZandrea Ambrose Cytoplasmic CPSF6 Regulates HIV-1 Capsid Trafficking and Infection in a Cyclophilin A-Dependent Manner. mBio 2021, 12, -, 10.1128/mbio.03142-20.
  17. David Alejandro Bejarano; Ke Peng; Vibor Laketa; Kathleen Börner; K Laurence Jost; Bojana Lucic; Bärbel Glass; Marina Lusic; Barbara Müller; Hans-Georg Kräusslich; et al. HIV-1 nuclear import in macrophages is regulated by CPSF6-capsid interactions at the nuclear pore complex. eLife 2019, 8, -, 10.7554/elife.41800.
  18. Vasudevan Achuthan; Jill M. Perreira; Gregory A. Sowd; Maritza Puray-Chavez; William M. McDougall; Adriana Paulucci-Holthauzen; Xiaolin Wu; Hind J. Fadel; Eric M. Poeschla; Asha S. Multani; et al.Stephen H. HughesStefan G. SarafianosAbraham L. BrassAlan N. Engelman Capsid-CPSF6 Interaction Licenses Nuclear HIV-1 Trafficking to Sites of Viral DNA Integration. Cell Host & Microbe 2018, 24, 392-404.e8, 10.1016/j.chom.2018.08.002.
  19. KyeongEun Lee; Zandrea Ambrose; Thomas Martin; Ilker Oztop; Alok Mulky; John G. Julias; Nick Vandegraaff; Joerg G. Baumann; Rui Wang; Wendy Yuen; et al.Taichiro TakemuraKenneth SheltonIchiro TaniuchiYuan LiJoseph SodroskiDan R. LittmanJohn M. CoffinStephen H. HughesDerya UnutmazAlan EngelmanVineet N. KewalRamani Flexible Use of Nuclear Import Pathways by HIV-1. Cell Host & Microbe 2010, 7, 221-233, 10.1016/j.chom.2010.02.007.
  20. Jiying Ning; Zhou Zhong; Douglas Fischer; Gemma Harris; Simon C. Watkins; Zandrea Ambrose; Peijun Zhang; Truncated CPSF6 Forms Higher-Order Complexes That Bind and Disrupt HIV-1 Capsid. Journal of Virology 2018, 92, e00368-18, 10.1128/jvi.00368-18.
  21. Akash Bhattacharya; Steven L. Alam; Thomas Fricke; Kaneil Zadrozny; Jaroslaw Sedzicki; Alexander B. Taylor; Borries Demeler; Owen Pornillos; Barbie K. Ganser-Pornillos; Felipe Diaz-Griffero; et al.Dmitri N. IvanovMark Yeager Structural basis of HIV-1 capsid recognition by PF74 and CPSF6. Proceedings of the National Academy of Sciences 2014, 111, 18625-18630, 10.1073/pnas.1419945112.
  22. Alberto De Iaco; Federico Santoni; Anne Vannier; Michel Guipponi; Stylianos Antonarakis; Jeremy Luban; TNPO3 protects HIV-1 replication from CPSF6-mediated capsid stabilization in the host cell cytoplasm. Retrovirology 2013, 10, 20-20, 10.1186/1742-4690-10-20.
  23. Stéphanie De Houwer; Jonas Demeulemeester; Wannes Thys; Susana Rocha; Lieve Dirix; Rik Gijsbers; Frauke Christ; Zeger Debyser; The HIV-1 Integrase Mutant R263A/K264A Is 2-fold Defective for TRN-SR2 Binding and Viral Nuclear Import. Journal of Biological Chemistry 2014, 289, 25351-25361, 10.1074/jbc.m113.533281.
  24. Vicky G. Tsirkone; Jolien Blokken; Flore De Wit; Jolien Breemans; Stéphanie De Houwer; Zeger Debyser; Frauke Christ; Sergei V. Strelkov; N-terminal half of transportin SR2 interacts with HIV integrase. Journal of Biological Chemistry 2017, 292, 9699-9710, 10.1074/jbc.m117.777029.
  25. Hulme, A.E.; Kelley, Z.; Foley, D.; Hope, T.J. Complementary assays reveal a low level of CA associated with viral complexes in the nuclei of HIV-1-infected cells. J. Virol. 2015, 89, 5350–5361.
  26. Hulme, A.E.; Kelley, Z.; Okocha, E.A.; Hope, T.J. Identification of capsid mutations that alter the rate of HIV-1 uncoating in infected cells. J. Virol. 2015, 89, 643–651.
  27. Ingram, Z.; Taylor, M.; Okland, G.; Martin, R.; Hulme, A.E. Characterization of HIV-1 uncoating in human microglial cell lines. Virol. J. 2020, 17, 1–12.
  28. Mamede, J.I.; Cianci, G.C.; Anderson, M.R.; Hope, T.J. Early cytoplasmic uncoating is associated with infectivity of HIV-1. Proc. Natl. Acad. Sci. USA 2017, 114, E7169–E7178.
  29. Borrenberghs, D.; Dirix, L.; De Wit, F.; Rocha, S.; Blokken, J.; De Houwer, S.; Gijsbers, R.; Christ, F.; Hofkens, J.; Hendrix, J. Dynamic oligomerization of integrase orchestrates HIV nuclear entry. Sci. Rep. 2016, 6, 36485.
  30. Bönisch, I.Z.; Dirix, L.; Lemmens, V.; Borrenberghs, D.; De Wit, F.; Vernaillen, F.; Rocha, S.; Christ, F.; Hendrix, J.; Hofkens, J. Capsid-labelled HIV to investigate the role of capsid during nuclear import and integration. J. Virol. 2020, 94, e01024-19.
  31. Francis, A.C.; Melikyan, G.B. Single HIV-1 imaging reveals progression of infection through CA-dependent steps of docking at the nuclear pore, uncoating, and nuclear transport. Cell Host Microbe 2018, 23, 536–548.e6.
  32. Lelek, M.; Di Nunzio, F.; Zimmer, C. FlAsH-PALM: Super-Resolution Pointillist Imaging with FlAsH-Tetracysteine Labeling. In Exocytosis and Endocytosis; Springer: Berlin/Heidelberg, Germany, 2014; pp. 183–193.
  33. Burdick, R.C.; Li, C.; Munshi, M.; Rawson, J.M.; Nagashima, K.; Hu, W.-S.; Pathak, V.K. HIV-1 uncoats in the nucleus near sites of integration. Proc. Natl. Acad. Sci. USA 2020, 117, 5486–5493.
  34. Li, C.; Burdick, R.C.; Nagashima, K.; Hu, W.-S.; Pathak, V.K. HIV-1 cores retain their integrity until minutes before uncoating in the nucleus. Proc. Natl. Acad. Sci. USA 2021, 118, e2019467118.
Subjects: Virology
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to :
View Times: 559
Revisions: 2 times (View History)
Update Date: 31 May 2021